Number of new diagnoses · vulnerable population: senior 65 years of age or older
Screening probably leads to higher number of new diagnoses: systematic screening vs routine practice compared with routine practice (moderate certainty).
2 findings from 1 review
Number of new diagnoses · vulnerable population: senior 65 years of age or older
Systematic screening showed no clear difference in number of new diagnoses compared with opportunistic screening (low certainty).
1 finding from 1 review
All‐cause mortality in 30 days post operation · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes all‐cause mortality in 30 days post operation compared with no treatment (very low certainty).
1 finding from 1 review
Cardiac ischaemia indicated by ECG · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
1 finding from 1 review
Hypotension · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes side effect (hypotension) compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects: headache · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes side effect (headache) compared with placebo (very low certainty).
1 finding from 1 review
Acute myocardial infarction · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes acute myocardial infarction compared with no treatment (very low certainty).
1 finding from 1 review
Angina · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes angina pectoris compared with no treatment (very low certainty).
1 finding from 1 review
Cardiac ischaemia indicated by ECG · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes cardiac ischaemia indicated by ECG compared with no treatment (very low certainty).
1 finding from 1 review
Hypotension · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
1 finding from 1 review
Adverse effects: headache · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes side effect (headache) compared with no treatment (very low certainty).
1 finding from 1 review
All‐cause mortality in 30 days post operation · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes all‐cause mortality in 30 days post operation compared with placebo (very low certainty).
1 finding from 1 review
Acute myocardial infarction · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes acute myocardial infarction compared with placebo (very low certainty).
1 finding from 1 review
Angina · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
1 finding from 1 review
Intervention not reported
Medicine use · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall use of medicines · vulnerable population: senior 65 years of age or older
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Use of medicines for symptomatic conditions · vulnerable population: senior 65 years of age or older
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Use of medicines for asymptomatic conditions · vulnerable population: senior 65 years of age or older
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Cost · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Patient perspective · vulnerable population: senior 65 years of age or older
1 finding from 1 review
no estimate extracted
Studies not reported
Low